El valor de la selección de pacientes en NSCLC

7 / 30

Reference Antibodies N Interobserver concordance
Ratcliffe, MJ et al.
Clin Cancer Res 2017 SP263, 28-8, 22C3 200 85% for PD-L1 threshold 50%; 76% for 1%
Cooper, W et al. J
Thorac Oncol 2017 22C3 120 84% for PD-L1 threshold 50%; 72% for 1%
Rehman, JA et al.
Mod Pathol 2017 SP142 35 94%
Rimm, DL et al. JAMA
Oncol 2017 SP142, 28-8, 22C3, E1L3N 90 86%
Four key publications for PD-L1
IHC interobserver comparison in
NSCLC